Company Intelligence
SFA Therapeutics
SFA Therapeutics provides enterprise-grade artificial intelligence solutions, delivering specialized Regulating the immune system to block cancer & autoimmune diseases technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Philadelphia, United States
- Website
- sfatherapeutics.com
- Founded
- 2021
- Employees
- 4
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
SFA Therapeutics is a Healthcare AI company based in Philadelphia, United States, founded in 2021.
SFA Therapeutics develops regulating the immune system to block cancer & autoimmune diseases.
What it builds
Regulating the immune system to block cancer & autoimmune diseases
Why It Matters
SFA Therapeutics provides enterprise-grade artificial intelligence solutions, delivering specialized Regulating the immune system to block cancer & autoimmune diseases technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
SFA Therapeutics
Explore SFA Therapeutics by SFA Therapeutics. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
SFA Therapeutics
Industry
Products
Capabilities
- Regulating the immune system to block cancer & autoimmune diseases
Features
- Regulating the immune system to block cancer & autoimmune diseases
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does SFA Therapeutics do?
SFA Therapeutics specializes in artificial intelligence, developing Regulating the immune system to block cancer & autoimmune diseases to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is SFA Therapeutics based and when was it founded?
SFA Therapeutics is based in United States and was founded in 2021.
What are the main products offered by SFA Therapeutics?
The flagship platform from SFA Therapeutics is Regulating the immune system to block cancer & autoimmune diseases, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of SFA Therapeutics?
SFA Therapeutics primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.